Group 1: Xi'an Yichuang (科创板, 688) - The company is set to issue shares at a price of 8.62 yuan, with a total market capitalization of 30.17 billion yuan [2] - The main revenue sources include testing wafers (43.68%), semiconductor silicon polishing wafers (39.16%), and semiconductor silicon epitaxial wafers (16.66%) [2] - The company has become the largest producer and seller in mainland China, with a strong demand forecast for chips driven by emerging applications like artificial intelligence [2][3] Group 2: Heyuan Biological (科创板, 688) - The company plans to issue shares at a price of 29.06 yuan, with a total market capitalization of 7.789 billion yuan [5] - It utilizes a rice endosperm cell bioreactor technology platform (OryzPur) to develop a comprehensive range of pharmaceuticals [5] - The company is a pioneer in using rice endosperm cell bioreactors for producing human serum albumin, which has significant clinical demand and market potential in China [6] Group 3: Changjiang Energy Technology (北交所, 920) - The company will issue shares at a price of 5.33 yuan, with an issuance price-to-earnings ratio of 14.99 [8] - It focuses on the design of energy and chemical specialized equipment, including heat exchange equipment, storage equipment, carbon capture equipment, and hydrogen energy equipment [8] - The company's core product, electro-dehydration equipment, is critical for oil extraction, ensuring that crude oil meets export standards [8]
【10月16日IPO雷达】西安奕材申购、禾元生物缴款、长江能科上市